Common | ||||||||||||||||||||
Debentures | Stock | |||||||||||||||||||
Shares of Common | Owned | Owned | ||||||||||||||||||
Principal Amount | Stock Beneficially | Common Stock | After | After | ||||||||||||||||
of Debentures | Owned Upon | Offered Upon | Completion | Completion | ||||||||||||||||
Beneficially Owned | Conversion of | Conversion of | of | of | ||||||||||||||||
Name | and Offered | Debentures(1) | Debentures(1) | Offering(2) | Offering(2) | |||||||||||||||
Bank Austria Cayman Islands Ltd. |
3,000,000 | 83,194 | 83,194 | 0 | 0 | |||||||||||||||
Basso Fund Ltd. |
842,000 | 23,350 | 23,350 | 0 | 0 | |||||||||||||||
Basso Holdings Ltd. |
6,558,000 | 181,863 | 181,863 | 0 | 0 | |||||||||||||||
Basso Multi-Strategy Holding Fund Ltd. |
2,600,000 | 72,102 | 72,102 | 0 | 0 | |||||||||||||||
City of Southfield Fire and Police
Retirement System c/o Income Research &
Management |
280,000 | 7,764 | 7,764 | 0 | 0 |
Common | ||||||||||||||||||||
Debentures | Stock | |||||||||||||||||||
Shares of Common | Owned | Owned | ||||||||||||||||||
Principal Amount | Stock Beneficially | Common Stock | After | After | ||||||||||||||||
of Debentures | Owned Upon | Offered Upon | Completion | Completion | ||||||||||||||||
Beneficially Owned | Conversion of | Conversion of | of | of | ||||||||||||||||
Name | and Offered | Debentures(1) | Debentures(1) | Offering(2) | Offering(2) | |||||||||||||||
Commonwealth Professional Assurance Company
c/o Income Research & Management |
910,000 | 25,235 | 25,235 | 0 | 0 | |||||||||||||||
Concord Hospital Employees Pension Fund c/o
Income Research & Management |
235,000 | 6,516 | 6,516 | 0 | 0 | |||||||||||||||
Concord Hospital Non-Pension Fund c/o Income
Research & Management |
395,000 | 10,953 | 10,953 | 0 | 0 | |||||||||||||||
Deutsche Bank AG London |
17,000,000 | 471,437 | 471,437 | 0 | 0 | |||||||||||||||
Deutsche Bank Securities Inc. |
16,000,000 | 443,705 | 443,705 | 0 | 0 | |||||||||||||||
Excellus Health Plan c/o Income Research &
Management |
4,470,000 | 123,960 | 123,960 | 0 | 0 | |||||||||||||||
JNL Series Trust JNL/T. Rowe Price Value
Fund (3) |
3,070,000 | 85,136 | 85,136 | 0 | 126,700 | |||||||||||||||
Mag Mutual Insurance Company c/o Income
Research & Management |
550,000 | 15,252 | 15,252 | 0 | 0 | |||||||||||||||
MedAmerica Insurance Company Hartford Trust
c/o Income Research & Management |
660,000 | 18,302 | 18,302 | 0 | 0 | |||||||||||||||
MedAmerica Insurance PA c/o Income Research
& Management |
1,610,000 | 44,647 | 44,647 | 0 | 0 | |||||||||||||||
Mig Assurance Convertible c/o Income
Research & Management |
1,045,000 | 28,979 | 28,979 | 0 | 0 | |||||||||||||||
T. Rowe Price Value Fund, Inc. (3) |
25,180,000 | 698,281 | 698,281 | 0 | 1,045,000 | |||||||||||||||
Tufts Associated Health Plans c/o Income
Research & Management |
1,520,000 | 42,152 | 42,152 | 0 | 0 | |||||||||||||||
UMass Memorial Health Care c/o Income
Research & Management |
410,000 | 11,369 | 11,369 | 0 | 0 | |||||||||||||||
UMass Memorial Investment Partnership c/o
Income Research & Management |
570,000 | 15,807 | 15,807 | 0 | 0 | |||||||||||||||
University of Massachusetts Convertible Bond
Portfolio c/o Income Research & Management |
405,000 | 11,231 | 11,231 | 0 | 0 | |||||||||||||||
Other (4) (5) |
565,256,000 |
(1) | Assumes conversion of all of the holders debentures at the maximum initial conversion rate of 27.7316 shares per debenture. However, the maximum conversion rate is subject to adjustment as described under Description of DebenturesConversion RightsConversion Rate Adjustments. As a result, the amount of common stock issuable upon conversion of the debentures may increase or decrease in the future. | |
(2) | Assumes that all of the debentures and/or all of the common stock into which the debentures are convertible are sold. No selling securityholder will own more than 1% of our outstanding common stock after the offering by such securityholder. | |
(3) | T. Rowe Price Associates, Inc. (T. Rowe Price Associates) serves as investment adviser with power to direct investments and/or sole power to vote the shares owned by the funds and accounts listed in the table above, as well as shares owned by certain other individual and institutional investors. For purposes of the reporting requirements of the Securities Exchange Act of 1934, T. Rowe Price Associates may be deemed to be the beneficial owner of all of the securities listed above as well as securities held by other clients; however, T. Rowe Price Associates expressly disclaims that it is, in fact, the beneficial owner of such securities. T. Rowe Price Associates is the wholly owned subsidiary of T. Rowe Price Group, Inc., which is a publicly traded financial services holding company. | |
(4) | Information about other selling securityholders will be set forth in an amendment to the registration statement of which this prospectus is a part or in prospectus supplements, as required. |
(5) | Assumes that any other holders of debentures, or any future transferees, pledgees, donees or successors of or from any such other holders of debentures, do not beneficially own any common stock other than the common stock issuable upon conversion of the debentures. |